Project Grant RF1AG091339
- The National Institute on Aging, under the Aging Research federal grant program (CFDA 93.866), has awarded a $3,030,409 project grant to the University of Arizona to investigate the sensitivity of semantic memory measures for detecting early-stage Alzheimer's disease (AD) pathology. Led by Principal Investigator Dr. Grilli, the project aims to ascertain the relationships between AD biomarkers, as measured by plasma assays and structural MRI, and various mechanisms of semantic memory...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $344,164 project grant to Northwestern University to develop "M4: Modules on Advanced Methodology When Modeling Multinational Data." The primary objectives are to: 1) create a training program in large-scale data analysis for the next generation of researchers, 2) instruct trainees on protective behavioral and social factors related to Alzheimer's disease and related dementias...
- The National Institute on Aging (NIA), under the Federal Aging Research program (CFDA 93.866), awarded a $245,148 project grant to Eyenexo LLC to develop an automated rodent behavior testing system for non-invasively assessing early-stage Alzheimer's disease (AD). The project aims to develop a behavior biomarker that can differentiate AD from normal aging by studying defensive behaviors triggered by looming stimuli, which are linked to early AD pathology in the midbrain region. The 2-year...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $131,813 Project Grant to the Trustees of Boston University (Boston University Medical Campus) on May 1, 2025. The grant aims to evaluate the effects of poverty alleviation policies, such as the Supplemental Nutrition Assistance Program (SNAP), on the risk and disparities of Alzheimer's disease and related dementias (AD/ADRD). The research will leverage data from the Health and...
- The National Institute on Aging (NIA) awarded a $2,208,923 Project Grant under the Aging Research program (CFDA 93.866) to the University of Washington (UW) on September 15, 2025. The grant, titled "AI-Enhanced and Culturally Adapted STAR-C for Latino Caregivers: A Stage I Pilot Study", aims to develop and integrate an AI-driven virtual assistant into the STAR-C intervention to provide real-time, culturally and linguistically tailored support for Latino caregivers managing behavioral...
- This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), has awarded a $299,553 Project Grant to Pilltrax Systems LLC to develop an enhanced medication management service for providers caring for African American and Latino older adults at risk of Alzheimer's disease and related dementias (ADRD). The proposed solution will comprise an electronic pill dispenser that sends medication adherence notifications, an adherence assessment tool, and a provider...
- This Project Grant award for $301,417 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to the University of Arizona. The award aims to develop innovative methods and tools for integrating data from Alzheimer's disease and related dementias (AD/ADRD) studies to address challenges posed by inconsistencies among evidence from different studies, particularly for comparative effectiveness research. The project has two main...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $627,212 Project Grant under the Aging Research program (CFDA 93.866) to the University of California, Berkeley (UC Berkeley) for the "Costa Rican Longevity and Healthy Aging Study (CRELES): Wave 4" research project. The grant, with a performance period from April 1, 2025 to December 31, 2029, will fund a long-term follow-up survey of over 3,500 Costa Rican adults aged 70 and...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $372,904 to The University of Texas Health Science Center at San Antonio to advance cross-national research on aging and cognitive function. The 5-year grant, awarded on September 20, 2025, supports an annual program that recruits, trains, and mentors 16 post-graduate participants dedicated to mastering Down syndrome (DS) clinical research. The program offers hands-on DS clinical...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $2,465,320 project grant to Arizona State University (ASU) to develop a performance-based measure of daily function for screening Hispanic/Latino older adults for Alzheimer's disease (AD) risk. The award period spans from Sep 15, 2025 to Sep 14, 2029. The goal is to leverage the existing MindCrowd electronic cohort to evaluate a newly developed, brief, and simple behavioral test (the "Bean Game") that measures daily functioning and is associated with cognition, with the aim of improving early-stage AD screening for Hispanic/Latino populations who are 1.5 times more likely to develop AD but are often diagnosed later in the disease process and underrepresented in clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 9/12/25 |